Overview
N8 Medical, LLC, a clinical-stage medical device company, is at the forefront of commercializing innovative medical devices enhanced with a novel class of active compounds known as Ceragenins.
N8 Medical’s goal is to revolutionize the safety of indwelling medical devices and implants. By applying our innovative CeraShield coating to these devices, we aim to prevent Hospital-Acquired Infections (HAIs), thereby reducing the reliance on antibiotics and combating Antimicrobial Resistance (AMR).
- The development of CeraShield, a specialized coating for medical devices, aimed at preventing infections.
- Through our subsidiary, Kinnear Pharmaceuticals (www.kinnearpharma.com), we're advancing therapeutic research and drug development. Our focus is on creating treatments for a range of conditions, including cystic fibrosis (CF) and Kostmann’s disease, leveraging the unique properties of Ceragenins that mimic the activity of naturally occurring innate immune system compounds such as LL-37.
